Quality of life in men and women with arterial hypertension. Results of BOLERO programm
Antihypertensive activity of slow-releasing indapamide (Ravel SR) and quality of life (QOT) in patients with arterial hypertension (AH) was investigated in BOTERO programm. Initially QOT in women was lower, then in men because of frequent headaches, dizziness, violation of the capacity for work, increased fatigability, uneasiness, depression. Tow quality of life inpatients with AH was related to coronary heart disease, duration of AH, level of blood pressure, and preceding stroke, high heart rate, body mass index in women and age in men. The QOT in women increases as a result of mono- or combined therapy with Ravel SR. Characteristics, related to increase of QOT irrespective of sex, were initially low rate of QOT, greater decrease of blood pressure, younger age. The QOT changes less in women with coronary heart disease and preceding stroke, larger circumference of waist, and in men with high body mass index.